Cryptocurrency & Digital Assets

A new US-China partnership secures a vital supply of Lu-177, aiming to accelerate the development and delivery of targeted cancer therapies in China.

The Royal Canadian Mint will issue a special glow-in-the-dark two-dollar coin to celebrate 50 years of the iconic CN Tower, sparking collector excitement.

A key recommendation for the drug BIMZELX could soon give Quebec patients a powerful new weapon against the debilitating skin disease hidradenitis suppurativa.

Agora Data and Figure have tokenized auto loans, making them investable assets on the blockchain. This industry-first could reshape auto finance forever.

In a major leadership shuffle, co-founder Kevin McCrystle will take the CEO reins to steer the company's focus toward AI, data services, and M&A.

As youth sports costs skyrocket, Winmark's Play It Again Sports enlists new pro athletes to champion its resale model and make sports accessible for all.

The Predictive Index names AI entrepreneur Lance Neuhauser as CEO, signaling a major push to merge 70 years of behavioral science with cutting-edge AI.

Pioneering period care brand Natracare rejects corporate buyouts, transitioning to an Employee Ownership Trust to permanently protect its ethical mission.

Just years after mass closures, Metroland is betting on a new monthly print model to revive local journalism and fight misinformation. Is this a new era?

A new RNA drug shows promise by reducing harmful belly fat while preserving muscle, but modest overall weight loss in early trials spooks investors.

Australian giant Cobram Estate Olives acquires #1 US brand California Olive Ranch, creating a new global leader in the extra virgin olive oil market.

China Mobile's new Global Intelligence Center in Hong Kong aims to supercharge the city's AI sector and serve as a key node in Beijing's global ambitions.

Italy's top fashion retailer OVS launches its second Indian store in Mumbai, signaling a major push into the nation's competitive apparel market.

The Killers will rock the UCL Final Kick Off Show. We dive into Pepsi's strategy and the unstoppable rise of the pre-game spectacle in global sports.

As homeowners face high interest rates, companies like Unison are turning home equity into a new, tradable asset class for institutional investors.

Ono Pharma's application for ripretinib could bring a vital new treatment to Japanese GIST patients who have exhausted all other options.

With revenues up but losses widening, Arverne Group is aggressively investing in geothermal energy and lithium to secure France's energy independence.

The cannabis giant reports falling revenue and deep annual losses, but bets its future on a Florida expansion and the hope of federal cannabis reform.

A new 750-patient clinical trial is underway to provide definitive evidence for advanced thrombectomy, potentially changing how deadly blood clots are treated.

Cambria is liquidating its cannabis ETF after years of underperformance, a move that reflects the harsh realities of a volatile and complex market.